Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 4/20 | 0.50 |
| ▸ | PIK3CA known ✓ | P42336 | 1/20 | 0.47 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.45 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.45 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.91 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.91 |
| ▸ | CASP1 | P29466 | 1/20 | 0.91 |
| ▸ | CASP7 | P55210 | 1/20 | 0.91 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.91 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 6/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL367451 | 1.00 | CYP3A4 (0.91) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3134351 | 1.00 | CYP3A4 (0.91) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL39680 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL269980 | 1.00 | CYP3A4 (0.91) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL9099015 | 1.00 | CYP3A4 (0.91) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL6753846 | 0.96 | CYP3A4 (0.83) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL30108424 | 0.96 | CYP3A4 (0.83) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL5964581 | 0.96 | CYP3A4 (0.83) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL21523286 | 0.96 | CYP3A4 (0.83) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL7154212 | 0.96 | CYP3A4 (0.83) | CYP3A4ALOX15CASP1CASP7SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8458 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4677362-A1 | ENZYME LINKED IMMUNOASSAY WITH DIFFUSION RATE LIMITING MEDIUM | Elleon Biotech Limited (HK) | 2026-01-14 | — | — | EP | claimed |
| WO-2025217532-A1 | DEVICES AND METHODS FOR DETECTING DISEASES | CONTROLPOINT INC. (US) | 2025-10-16 | — | — | WO | claimed |
| WO-2025062323-A1 | ENZYME LINKED IMMUNOASSAY WITH DIFFUSION RATE LIMITING MEDIUM | ELLEON BIOTECH LIMITED (CN) | 2025-03-27 | — | — | WO | claimed |
| US-20250092459-A1 | NANOZYME-CATALYSED DETECTION OF NUCLEIC ACIDS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-03-20 | — | — | US | claimed |
| WO-2025048611-A1 | DUAL IMMUNODIAGNOSTIC CHIP | 한국기초과학지원연구원 | 2025-03-06 | — | — | WO | claimed |
| US-20250052746-A1 | DIAGNOSTIC ASSAY USING MAGNETIC PARTICLES | Osler Diagnostics Limited (GB) | 2025-02-13 | — | — | US | claimed |
| WO-2025032060-A1 | CRISPR-COACERVATE SYSTEM | ETH ZURICH (CH) | 2025-02-13 | — | — | WO | claimed |
| EP-4506464-A1 | CRISPR-COACERVATE SYSTEM | ETH Zurich (CH) | 2025-02-12 | — | — | EP | claimed |
| US-12209916-B2 | Composition for temperature sensors including graphene oxide, DNAzyme and PNA and temperature sensing method using the same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2025-01-28 | — | — | US | claimed |
| EP-4467163-A2 | SELF INDICATING ANTIMICROBIAL CHEMISTRY | Ecolab USA Inc. (US) | 2024-11-27 | — | — | EP | claimed |
| EP-0581882-B1 | PROCESS OF SCREENING PLASMA SAMPLES FOR EFFECTIVE ANTIBODY TITERS AGAINST RESPIRATORY VIRUSES | MASSACHUSETTS HEALTH RES (US) | 1998-01-07 | — | — | EP | claimed |
| EP-0811067-A1 | EQUINE ARTERITIS VIRUS PEPTIDES, ANTIBODIES AND THEIR USE IN A DIAGNOSTIC TEST | MINISTER OF AGRICULTURE FISHERIES AND FOOD IN HER BRITANNIC MAJESTY'S GOV. OF THE U.K. OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1997-12-10 | — | — | EP | claimed |
| WO-1997011369-A1 | METHOD FOR QUANTITATING AN INFLAMMATORY RESPONSE | MERCK & CO., INC. (US) | 1997-03-27 | — | — | WO | claimed |
| US-5582827-A | Process of screening plasma samples for effective antibody titers against respiratory viruses | MASSACHUSETTS HEALTH RESEARCH INSTITUTE, INC. (US) | 1996-12-10 | — | — | US | claimed |
| WO-1996033403-A1 | SENSOR | THE MANCHESTER METROPOLITAN UNIVERSITY (GB) | 1996-10-24 | — | — | WO | claimed |
| WO-1995019438-A1 | EQUINE ARTERITIS VIRUS PEPTIDES, ANTIBODIES AND THEIR USE IN A DIAGNOSTIC TEST | THE MINISTER OF AGRICULTURE, FISHERIES AND FOOD IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1995-07-20 | — | — | WO | claimed |
| US-5412077-A | Effective antibody titers against respiratory viruses | MASSACHUSETTS HEALTH RESEARCH INSTITUTE, INC. (US) | 1995-05-02 | — | — | US | claimed |
| US-5188942-A | Method for determining bluetongue virus antibodies in serum | CONSULTANTS FOR APPLIED BIOSCIENCES, INC. (US) | 1993-02-23 | — | — | US | claimed |
| US-5025107-A | Process for coproduction of arylene diamine dihalides and alkyl halides | EASTMAN KODAK COMPANY (US) | 1991-06-18 | — | — | US | claimed |
| US-4340670-A | Method of using over the counter swab kit for self detection of gonorrhea in the male using tetramethyl chromogen ampul | MENNEN FREDERICK C | 1982-07-20 | — | — | US | claimed |